Kenvue ( KVUE) lost 7.47% of its stock value on Sept. 22's session after President Donald Trump and Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr. linked acetaminophen, the active ingredient in Tylenol, to autism and attention deficit hyperactivity disorder.

Donald Trump went after Tylenol again in a Truth Social post Friday, urging pregnant women to avoid the drug, causing parent company Kenvue’s shares to slip. President Trump warned women to avoid Tylenol “unless absolutely necessary” in a post on Truth Social Friday.

Robert Andrews would forever remember when his phone rang on Friday, September 30, 1982. He was assistant director for PR at Johnson & Johnson, whose pain reliever, Tylenol, was the […]

A year ago, the maker of Tylenol lauded a federal judge’s dismissal of hundreds of lawsuits alleging the popular painkiller caused autism in children whose mothers took it during pregnancy. The company,

"Trump's cringe-worthy struggle with 'acetaminophen' leaves internet in stitches. Find out why America is buzzing. #Trump #ViralMoment"

Kenvue shares rose in premarket trading Tuesday, rebounding after a record low the day before, even as U.S. President Donald Trump linked Tylenol to autism risk during pregnancy at a White House press conference.

The FDA reapproved a GSK drug that stopped being sold more than 25 years ago, as part of a push to identify potential treatments for autism

Families appealing the dismissal of their lawsuits alleging that Kenvue's Tylenol or generic versions of the pain-relief medication caused their children's autism are asking an appeals court to consider President Donald Trump's new advice that pregnant women avoid the pain killer as it decides whether to revive their lawsuits.